176 related articles for article (PubMed ID: 9687584)
1. Regulation of adenylyl cyclase isozymes on acute and chronic activation of inhibitory receptors.
Nevo I; Avidor-Reiss T; Levy R; Bayewitch M; Heldman E; Vogel Z
Mol Pharmacol; 1998 Aug; 54(2):419-26. PubMed ID: 9687584
[TBL] [Abstract][Full Text] [Related]
2. Opiate-induced adenylyl cyclase superactivation is isozyme-specific.
Avidor-Reiss T; Nevo I; Saya D; Bayewitch M; Vogel Z
J Biol Chem; 1997 Feb; 272(8):5040-7. PubMed ID: 9030567
[TBL] [Abstract][Full Text] [Related]
3. Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: role of beta gamma subunits in transducing enhanced activity of the type VI isoform.
Thomas JM; Hoffman BB
Mol Pharmacol; 1996 May; 49(5):907-14. PubMed ID: 8622641
[TBL] [Abstract][Full Text] [Related]
4. Acute and chronic activation of the mu-opioid receptor with the endogenous ligand endomorphin differentially regulates adenylyl cyclase isozymes.
Nevo I; Avidor-Reiss T; Levy R; Bayewitch M; Vogel Z
Neuropharmacology; 2000 Jan; 39(3):364-71. PubMed ID: 10698002
[TBL] [Abstract][Full Text] [Related]
5. Differential superactivation of adenylyl cyclase isozymes after chronic activation of the CB(1) cannabinoid receptor.
Rhee MH; Nevo I; Avidor-Reiss T; Levy R; Vogel Z
Mol Pharmacol; 2000 Apr; 57(4):746-52. PubMed ID: 10727521
[TBL] [Abstract][Full Text] [Related]
6. Inhibition and superactivation of the calcium-stimulated isoforms of adenylyl cyclase: role of Gbetagamma dimers.
Steiner D; Avidor-Reiss T; Schallmach E; Saya D; Vogel Z
J Mol Neurosci; 2005; 27(2):195-203. PubMed ID: 16186630
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes.
Rhee MH; Bayewitch M; Avidor-Reiss T; Levy R; Vogel Z
J Neurochem; 1998 Oct; 71(4):1525-34. PubMed ID: 9751186
[TBL] [Abstract][Full Text] [Related]
8. Regulation of adenylate cyclase type VIII splice variants by acute and chronic Gi/o-coupled receptor activation.
Steiner D; Avidor-Reiss T; Schallmach E; Butovsky E; Lev N; Vogel Z
Biochem J; 2005 Mar; 386(Pt 2):341-8. PubMed ID: 15537392
[TBL] [Abstract][Full Text] [Related]
9. A novel mechanism for coupling of m4 muscarinic acetylcholine receptors to calmodulin-sensitive adenylyl cyclases: crossover from G protein-coupled inhibition to stimulation.
Dittman AH; Weber JP; Hinds TR; Choi EJ; Migeon JC; Nathanson NM; Storm DR
Biochemistry; 1994 Feb; 33(4):943-51. PubMed ID: 8305442
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of AC-II activity following chronic agonist exposure is modulated by phosphorylation.
Schallmach E; Steiner D; Vogel Z
J Mol Neurosci; 2006; 29(2):115-22. PubMed ID: 16954601
[TBL] [Abstract][Full Text] [Related]
11. Bimodal regulation of cyclic AMP by muscarinic receptors. Involvement of multiple G proteins and different forms of adenylyl cyclase.
Onali P; Olianas MC
Life Sci; 1995; 56(11-12):973-80. PubMed ID: 10188801
[TBL] [Abstract][Full Text] [Related]
12. Role of G protein betagamma subunits in muscarinic receptor-induced stimulation and inhibition of adenylyl cyclase activity in rat olfactory bulb.
Olianas MC; Ingianni A; Onali P
J Neurochem; 1998 Jun; 70(6):2620-7. PubMed ID: 9603229
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of adenylyl cyclase type V by the dopamine D3 receptor.
Robinson SW; Caron MG
Mol Pharmacol; 1997 Sep; 52(3):508-14. PubMed ID: 9281614
[TBL] [Abstract][Full Text] [Related]
14. Alterations in detergent solubility of heterotrimeric G proteins after chronic activation of G(i/o)-coupled receptors: changes in detergent solubility are in correlation with onset of adenylyl cyclase superactivation.
Bayewitch ML; Nevo I; Avidor-Reiss T; Levy R; Simonds WF; Vogel Z
Mol Pharmacol; 2000 Apr; 57(4):820-5. PubMed ID: 10727531
[TBL] [Abstract][Full Text] [Related]
15. Morphine-related metabolites differentially activate adenylyl cyclase isozymes after acute and chronic administration.
Eckhardt K; Nevo I; Levy R; Mikus G; Eichelbaum M; Vogel Z
FEBS Lett; 2000 Mar; 470(3):309-14. PubMed ID: 10745087
[TBL] [Abstract][Full Text] [Related]
16. Adenylyl cyclase type II activity is regulated by two different mechanisms: implications for acute and chronic opioid exposure.
Schallmach E; Steiner D; Vogel Z
Neuropharmacology; 2006 Jun; 50(8):998-1005. PubMed ID: 16545401
[TBL] [Abstract][Full Text] [Related]
17. mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
Yoshimura M; Ikeda H; Tabakoff B
Mol Pharmacol; 1996 Jul; 50(1):43-51. PubMed ID: 8700117
[TBL] [Abstract][Full Text] [Related]
18. Lithium preferentially inhibits adenylyl cyclase V and VII isoforms.
Mann L; Heldman E; Shaltiel G; Belmaker RH; Agam G
Int J Neuropsychopharmacol; 2008 Jun; 11(4):533-9. PubMed ID: 18205980
[TBL] [Abstract][Full Text] [Related]
19. Identity of adenylyl cyclase isoform determines the G protein mediating chronic opioid-induced adenylyl cyclase supersensitivity.
Ammer H; Christ TE
J Neurochem; 2002 Nov; 83(4):818-27. PubMed ID: 12421353
[TBL] [Abstract][Full Text] [Related]
20. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]